Correction: harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy.

Arnon TI., Markel G., Bar-Ilan A., Hanna J., Fima E., Benchetrit F., Galili R., Cerwenka A., Benharroch D., Sion-Vardy N., Porgador A., Mandelboim O.

DOI

10.1371/journal.pone.0128052

Type

Journal article

Journal

PLoS One

Publication Date

2015

Volume

10

Permalink Original publication